原发性肝癌经肝动脉化疗栓塞术后中西医结合康复专家共识

国家艾滋病和病毒性肝炎等重大传染病防治科技专项“中医药延缓乙型肝炎相关肝癌进展的综合治疗方案研究”课题组; 中国医师协会中西医结合分会肿瘤专业委员会; 河南省康复医学会消化康复分会; 河南省中西医结合学会肝病分会

doi:10.3969/j.issn.1001-5256.2021.07.013

原发性肝癌经肝动脉化疗栓塞术后中西医结合康复专家共识

DOI: 10.3969/j.issn.1001-5256.2021.07.013

基金项目:

国家艾滋病和病毒性肝炎等重大传染病防治科技专项课题 (2018ZX10303502)

顾问：王灵台王融冰叶永安孙塑伦李秀惠郑玉玲赵文霞胡凯文

《原发性肝癌经肝动脉化疗栓塞术后中西医结合康复专家共识》编审专家名单(以姓氏笔画排序)：

执笔专家：马素平陈欣菊陈晓琦

成员：王永正(山东大学第二医院)，王涛(青岛大学附属烟台毓璜顶医院)，刘凌晓(复旦大学附属中山医院)，刘斌(山东大学第二医院)，池嘉昌(上海交通大学医学院附属仁济医院)，陈一平(福建医科大学附属第一医院)，张宁(中国人民解放军第五医学中心)，李玉亮(山东大学第二医院)，张世玺(商丘市立医院)，邵明义(河南中医药大学第一附属医院)，宋松林(华中科技大学同济医学院附属协和医院)，汪晓军(首都医科大学附属北京佑安医院)，何婷婷(中国人民解放军第五医学中心)，李臻(郑州大学第一附属医院)，陈颢(复旦大学附属肿瘤医院)，林征宇(福建医科大学附属第一医院)，罗保平(湖北省中医院)，林瑞祥(福建医科大学附属第一医院)，郝尧坤(河南中医药大学第一附属医院)，赵晴(河南中医药大学第一附属医院)，赵强(河南中医药大学第一附属医院)，荣震(广西医科大学第一附属医院)，钱坤(华中科技大学同济医学院附属协和医院)，唐喆(浙江大学医学院附属第二医院)，郭志忠(河南省中医院)，郭彦伟(郑州大学第五附属医院)，姬卫国(河南中医药大学第三附属医院)，路太英(郑州大学第一附属医院)，靳勇(苏州大学附属第二医院)，翟博(上海交通大学医学院附属仁济医院)，熊斌(华中科技大学同济医学院附属协和医院)，黎海亮(河南省肿瘤医院)，冀爱英(河南中医药大学第一附属医院)

利益冲突声明：所有作者均声明不存在利益冲突

详细信息

通信作者: 陈欣菊，chenxinju1215@126.com；马素平，masuping@163.com

中图分类号: R735.7
计量
- 文章访问数: 788
- HTML全文浏览量: 434
- PDF下载量: 185
- 被引次数: 0
出版历程
- 收稿日期: 2021-05-29
- 录用日期: 2021-05-29
- 出版日期: 2021-07-20

Expert consensus on integrated traditional Chinese and Western medicine rehabilitation after transcatheter arterial chemoembolization for primary liver cancer

Research funding:

National Science and Technology Major Project of the Ministry of Science and Technology of China - Prevention and Treatment of Major Infectious Diseases such as AIDS and Viral Hepatitis (2018ZX10303502)

摘要

- 肝肿瘤 /
- 化学栓塞, 治疗性 /
- 中西医结合疗法 /
- 共识
- Liver Neoplasms /
- Chemoembolization, Therapeutic /
- TCM WM THERAPY /
- Consensus

HTML全文

参考文献(30)

[1]	ZHENG RS, SUN KX, ZHANG SW, et al. Report of cancer epidemiology in China, 2015[J]. Chin J Oncol, 2019, 41(1): 19-28. DOI: 10.3760/cma.j.issn.0253-3766.2019.01.008. 郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28. DOI: 10.3760/cma.j.issn.0253-3766.2019.01.008.
[2]	Bureau of Medical AdministrationNational Health Commission of the People's Republic of China. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)[J]. J Clin Hepatol, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007. 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007.
[3]	LIU YY, LAI JX. Minimally invasive interventional treatment of liver cancer[J/CD]. Chin J Hepat Surg(Electronic Edition), 2020, 9(3): 201-205. DOI: 10.3877/cma.j.issn.2095-3232.2020.03.001. 刘允怡, 赖俊雄. 肝癌微创介入治疗[J/CD]. 中华肝脏外科手术学电子杂志, 2020, 9(3): 201-205. DOI: 10.3877/cma.j.issn.2095-3232.2020.03.001.
[4]	HE S, XUE H. Current status and evaluation of the treatment of primary liver cancer[J]. J Hepatobiliary Surg, 2000, 8(3): 162-164. DOI: 10.3969/j.issn.1006-4761.2000.03.002. 何生, 薛华. 原发性肝癌治疗现状与评价[J]. 肝胆外科杂志, 2000, 8(3): 162-164. DOI: 10.3969/j.issn.1006-4761.2000.03.002.
[5]	SCHNEEWEIβ S, HORGER M, KETELSEN D, et al. Complications after TACE in HCC - Komplikationen nach transarterieller Chemoembolisation (TACE) beim hepatozellulären Karzinom[J]. Rofo, 2015, 187(2): 79-82. DOI: 10.1055/s-0034-1369532.
[6]	TONGSIRI N, SUBWONGCHAROEN S, TREEPONGKARUNA SA. The impact of transarterial chemoembolization for advanced stage hepatocellular carcinoma: A single center experience[J]. J Med Assoc Thai, 2017, 100(1): 33-41. http://europepmc.org/abstract/MED/29911378
[7]	LIN XT, ZHANG RJ, LI FY, et al. A retrospective analysis of integrated traditional Chinese and Western medicine therapy for primary liver cancer[J]. J Chin Med Materls, 2020, 43(5): 1244-1247. DOI: 10.13863/j.issn1001-4454.2020.05.040. 林晓彤, 张荣杰, 李福阳, 等. 中西医结合治疗原发性肝癌的回顾性研究[J]. 中药材, 2020, 43(5): 1244-1247. DOI: 10.13863/j.issn1001-4454.2020.05.040.
[8]	CHENG ZW, CHENG W, XING DW, et al. Progress in the application of traditional Chinese medicine in the treatment of embolism syndrome after transcatheter arterial chemoembolization[J]. Jilin J Tradit Chin Med, 2019, 39(11): 1533-1536. DOI: 10.13463/j.cnki.jlzyy.2019.11.036. 程紫薇, 程伟, 邢东炜, 等. 中医药治疗肝动脉化疗栓塞术后栓塞综合征进展[J]. 吉林中医药, 2019, 39(11): 1533-1536. DOI: 10.13463/j.cnki.jlzyy.2019.11.036.
[9]	QIAN GJ, QU ZQ, CHEN H, et al. Side effects and complications of transcatheter arterial chemoembolization in treatment of liver cancer: An analysis of 1000 cases[J]. Chin J Hepatobiliary Surg, 2001, 7(1): 38-39. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHGD200101017.htm 钱国军, 曲增强, 陈汉, 等. 肝动脉栓塞化疗术治疗肝癌的副作用和并发症(附1000例报告)[J]. 中华肝胆外科杂志, 2001, 7(1): 38-39. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHGD200101017.htm
[10]	KE CQ, PENG EL, PENG QP, et al. Experience of diagnosis and treatment of the complications of primary hepatocellular car-cinoma after interventional therapy[J]. Mod Oncol, 2015, 23(18): 2634-2636. DOI: 10.3969/j.issn.1672-4992.2015.18.24. 柯传庆, 彭恩兰, 彭秋平, 等. 原发性肝癌介入术后并发症诊治经验[J]. 现代肿瘤医学, 2015, 23(18): 2634-2636. DOI: 10.3969/j.issn.1672-4992.2015.18.24.
[11]	LIU CJ. Clinical effect of transcatheter arterial chemoembolization combined with sequential or concurrent microwave ablation in treatment of large hepatocellular carcinoma and giant hepatocellular carcinoma[D]. Wuhan: Wuhan University, 2018. 刘传佳. 肝动脉化疗栓塞序贯与同步联合微波消融治疗大肝癌及巨大肝癌的临床研究[D]. 武汉: 武汉大学, 2018.
[12]	WANG L, LU LH, ZHONG CS. Clinical effect of magnesium isoglycyrrhizinate combined with reduced glutathione in the prevention and treatment of liver damage after transcatheter arterial chemoembolization for liver cancer[J]. Chin Hepatol, 2016, 21(1): 63-65. DOI: 10.3969/j.issn.1008-1704.2016.01.019. 王莉, 陆笼辉, 钟春生. 异甘草酸镁联合还原型谷胱甘肽防治肝癌TACE术后肝损害疗效观察[J]. 肝脏, 2016, 21(1): 63-65. DOI: 10.3969/j.issn.1008-1704.2016.01.019.
[13]	National Health Commission of the people's Republic of China. Guidelines for the diagnosis and treatment of cancer pain (2018 edition)[J]. Chin Clin Oncol, 2018, 23(10): 937-944. https://www.cnki.com.cn/Article/CJFDTOTAL-LCZL201810016.htm 中华人民共和国国家卫生健康委员会. 癌症疼痛诊疗规范(2018年版)[J]. 临床肿瘤学杂志, 2018, 23(10): 937-944. https://www.cnki.com.cn/Article/CJFDTOTAL-LCZL201810016.htm
[14]	SWARM RA, PAICE JA, ANGHELESCU DL, et al. Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2019, 17(8): 977-1007. DOI: 10.6004/jnccn.2019.0038.
[15]	ZHUANG XS, LI YX, XU T, et al. Clinical features of liver abscess after interventional treatment of liver cancer and related experience in prevention and treatment[J]. Clin J Med Offic, 2015, 43(12): 1298-1299. DOI: 10.16680/j.1671-3826.2015.12.27. 庄学山, 李奕鑫, 徐涛, 等. 肝癌介入治疗后并发肝脓肿临床特征与防治体会[J]. 临床军医杂志, 2015, 43(12): 1298-1299. DOI: 10.16680/j.1671-3826.2015.12.27.
[16]	Cooperative Group of Interventional Group, Chinese Society of Radiology, Chinese Medical Association. Expert consensus on technical operational standard of transcatheter arterial chemoembolization for primary hepatocellular carcinoma[J]. Chin J Radiol, 2011, 45(10): 908-912. DOI: 10.3760/cma.j.issn.1005-1201.2011.10.003. 中华医学会放射学分会介入学组协作组. 原发性肝细胞癌经导管肝动脉化疗性栓塞治疗技术操作规范专家共识[J]. 中华放射学杂志, 2011, 45(10): 908-912. DOI: 10.3760/cma.j.issn.1005-1201.2011.10.003.
[17]	DHAMIJA E, PAUL SB, GAMANAGATTI SR, et al. Biliary complications of arterial chemoembolization of hepatocellular carcinoma[J]. Diagn Interv Imaging, 2015, 96(11): 1169-1175. DOI: 10.1016/j.diii.2015.06.017.
[18]	LUO PF, FU L, CHEN XM. Formation and clinical significance of bile tumor after interventional treatment of liver cancer[J]. Chin J Radiol, 2000, 34(11): 757. DOI: 10.3760/j.issn:1005-1201.2000.11.010. 罗鹏飞, 符力, 陈晓明. 肝癌介入治疗后胆汁瘤的形成与临床意义[J]. 中华放射学杂志, 2000, 34(11): 757. DOI: 10.3760/j.issn:1005-1201.2000.11.010.
[19]	LIU YN. Value of off-bed activity in the early stage after interventional surgery in improving postoperative rehabilitation in patients with liver cancer[J]. Today Nurse, 2017, (11): 63-65. DOI: 10.3969/j.issn.1006-6411.2017.11.034. 刘亚男. 肝癌患者介入术后早期下床活动改善术后康复的价值[J]. 当代护士(上旬刊), 2017, (11): 63-65. DOI: 10.3969/j.issn.1006-6411.2017.11.034.
[20]	JIANG ZQ, PAN DM. Study on adverse reactions and complications of transarterial interven-tional therapy of primary liver cancer operation and nursing[J]. Systems Med, 2017, 2(24): 122-124. DOI: 10.19368/j.cnki.2096-1782.2017.24.122. 江芝芹, 潘冬梅. 经动脉介入治疗原发性肝癌术后不良反应及并发症的探讨与护理[J]. 系统医学, 2017, 2(24): 122-124. DOI: 10.19368/j.cnki.2096-1782.2017.24.122.
[21]	MA DM. Observation on the effect of air pressure treat preventing lower limbs deep vein thrombosis in paraplegic patients after surgery[J]. Clin Res, 2018, 26(10): 183-184. DOI: 10.3969/j.issn.1004-8650.2018.10.103. 马冬苗. 气压治疗预防截瘫患者术后下肢深静脉血栓形成的效果观察[J]. 临床研究, 2018, 26(10): 183-184. DOI: 10.3969/j.issn.1004-8650.2018.10.103.
[22]	ZHU YE, YU JX, YI XY, et al. Effect of implementing continuing care after interventional surgery for liver cancer[J]. Int J Nurs, 2021, 40(3): 549-553. DOI: 10.3760/cma.j.cn221370-20191008-00162. 朱英娥, 俞静娴, 裔馨颖, 等. 肝癌介入治疗术后延续性护理的实施效果[J]. 国际护理学杂志, 2021, 40(3): 549-553. DOI: 10.3760/cma.j.cn221370-20191008-00162.
[23]	YANG QP, LIANG J. Effect of holistic nursing intervention on urinary retention after interventional surgery for liver cancer[J]. Yunnan J Tradit Chin Med Mater Med, 2016, 37(2): 82-83. https://www.cnki.com.cn/Article/CJFDTOTAL-YZYY201602035.htm 杨秋萍, 梁键. 整体护理干预对肝癌介入术后尿潴留的影响[J]. 云南中医中药杂志, 2016, 37(2): 82-83. https://www.cnki.com.cn/Article/CJFDTOTAL-YZYY201602035.htm
[24]	CHENG Z. Traditional Chinese medicine syndrome characteristics before and after transcatheter arterial chemoembolization for primary liver cancer[D]. Hangzhou: Zhejiang Chinese Medical University, 2019. 程志. 原发性肝癌TACE介入治疗前后中医证候特点研究[D]. 杭州: 浙江中医药大学, 2019.
[25]	WANG D, WANG YH, LI H, et al. Clinical observation of granisetron combined with herb-separated moxibustion in the treatment of nausea and vomiting after interventional therapy for hepatocellular carcinoma[J]. Prog Mod Biomed, 2020, 20(12): 2359-2362. DOI: 10.13241/j.cnki.pmb.2020.12.035. 王聃, 王亚华, 李辉, 等. 格拉司琼联合隔药灸治疗肝癌介入术后恶心呕吐临床观察[J]. 现代生物医学进展, 2020, 20(12): 2359-2362. DOI: 10.13241/j.cnki.pmb.2020.12.035.
[26]	LI H, YU Q, WANG YH, et al. Efficacy observation of herb-partitioned moxibustion combined with medication in treating nausea and vomiting after liver cancer intervention therapy[J]. Shanghai J Acupunct Moxib, 2020, 39(7): 871-874. DOI: 10.13460/j.issn.1005-0957.2020.13.1026. 李辉, 于倩, 王亚华, 等. 隔药灸配合药物治疗肝癌介入术后恶心呕吐的疗效观察[J]. 上海针灸杂志, 2020, 39(7): 871-874. DOI: 10.13460/j.issn.1005-0957.2020.13.1026.
[27]	JI J, WEI GL, YIN GW, et al. Clinical observation on auricular points plaster therapy in treating adverse reaction of primary liver cancer after TACE[J]. Western J Traditl Chin Med, 2020, 33(10): 124-126. DOI: 10.12174/j.issn.1004-6852.2020.10.34. 吉晶, 魏国利, 尹国文, 等. 耳穴压豆治疗原发性肝癌TACE术后不良反应临床观察[J]. 西部中医药, 2020, 33(10): 124-126. DOI: 10.12174/j.issn.1004-6852.2020.10.34.
[28]	DAI HP, YE R, HUANG SM, et al. Clinical study on auricular acupoints bean-burying therapy for hepatocellular carcinoma after interventional therapy[J]. J Clin Med Pract, 2018, 22(12): 81-83. DOI: 10.7619/jcmp.201812024. 戴海萍, 叶然, 黄苏闽, 等. 耳穴埋籽干预肝癌介入术后疼痛的临床研究[J]. 实用临床医药杂志, 2018, 22(12): 81-83. DOI: 10.7619/jcmp.201812024.
[29]	GU YJ, QUAN CF, CHEN XJ. Clinical research on acupuncture combined with acupoint sticking in the treatment of stagnation of blood stasis type of cancer pain[J]. China J Chin Med, 2017, 32(12): 2307-2310. DOI: 10.16368/j.issn.1674-8999.2017.12.601. 顾亚娇, 权春分, 陈欣菊. 针刺联合消癌痛贴治疗瘀血停滞型癌性疼痛临床研究[J]. 中医学报, 2017, 32(12): 2307-2310. DOI: 10.16368/j.issn.1674-8999.2017.12.601.
[30]	LIN JY. Clinical effect of wrist-ankle acupuncture in treatment of pain after interventional treatment of liver cancer: An analysis of 36 cases[J]. Shanghai J Acupunct Moxib, 2014, 33(1): 60. DOI: 10.13460/j.issn.1005-0957.2014.01.0060. 林娟英. 腕踝针治疗肝癌介入治疗后疼痛36例[J]. 上海针灸杂志, 2014, 33(1): 60. DOI: 10.13460/j.issn.1005-0957.2014.01.0060.